Publicacións nas que colabora con Ana Casal Mouriño (30)

2025

  1. Use of mycophenolate mofetil for the treatment of fibrotic hypersensitivity pneumonitis

    American Journal of the Medical Sciences, Vol. 369, Núm. 1, pp. 24-34

2024

  1. Diabetes and obstructive sleep apnoea: A case-control study

    Medicina Clinica, Vol. 162, Núm. 2, pp. 49-55

  2. Effect of an intensive tobacco cessation program on the smoker narrative: A content analysis and grounded theory

    Tobacco Induced Diseases, Vol. 22

  3. Non-infectious pulmonary complications after haematopoietic progenitor transplantation: a diagnostic approach

    Journal of Thoracic Disease, Vol. 16, Núm. 12, pp. 8771-8781

  4. Relationship between obstructive sleep apnea and type 2 diabetes mellitus

    Medicina Clinica, Vol. 162, Núm. 8, pp. 363-369

  5. Smoking-related interstitial lung disease: A narrative review

    Chronic Respiratory Disease, Vol. 21

  6. Usefulness of a predictive model to hospitalize patients with low-risk community-acquired pneumonia

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 1, pp. 61-71

2023

  1. A pulmonary rehabilitation program reduces hospitalizations in chronic obstructive pulmonary disease patients: A cost‑effectiveness study

    Annals of Thoracic Medicine, Vol. 18, Núm. 4, pp. 190-198

  2. Advances in inhaled antibiotics for management of respiratory tract infections

    Current opinion in pulmonary medicine, Vol. 29, Núm. 3, pp. 160-167

  3. Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?

    Journal of Thoracic Disease, Vol. 15, Núm. 2, pp. 711-717

  4. Pleural effusion due to nonmalignant gastrointestinal disease

    ERJ Open Research, Vol. 9, Núm. 3

2022

  1. Cost-Effectiveness of a New Outpatient Pulmonology Care Model Based on Physician-to-Physician Electronic Consultation

    Canadian Respiratory Journal, Vol. 2022

  2. Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial

    European Respiratory Journal, Vol. 60, Núm. 2

  3. Pleuroparenchymal fibroelastosis: Clinical, radiological and histopathological features

    Respiratory Medicine, Vol. 191

  4. Pulmonary Manifestations of Primary Humoral Deficiencies

    Canadian Respiratory Journal, Vol. 2022

  5. Quality of life and persistent symptoms after hospitalization for COVID-19. A prospective observational study comparing ICU with non-ICU patients

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 69, Núm. 6, pp. 326-335

  6. Response to inhaled ceftazidime in patients with non-cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa

    Clinical Respiratory Journal, Vol. 16, Núm. 11, pp. 768-773

  7. Sarcoidosis. Disease progression based on radiological and functional course: Predictive factors

    Heart and Lung, Vol. 56, pp. 62-69

2021

  1. Evaluation of the impact of an integrated care pathway for pulmonary embolism: A quasi-experimental pre-post study

    Journal of Thoracic Disease, Vol. 13, Núm. 9, pp. 5373-5382

  2. Health Indicators in Hospitalized Patients With SARS-CoV-2 Pneumonia: A Comparison Between the First and Second Wave

    Archivos de Bronconeumologia, Vol. 57, Núm. 11, pp. 717-719